A fragment of antibody avoids the typical haemorrhages of new treatments for Alzheimer's
Recently, two immunotherapeutic Alzheimer's treatments using full antibodies have been approved, but it is known that they can cause brain haemorrhages as a side effect. The UAB Protein Design and Immunotherapy...








